TRICARE Manuals - Display Chap 7 Sect 2.3 (Change 16, Sep 13, 2024)

Medicine

Chapter 7

Section 2.3

Family Planning

Issue Date: August 26, 1985

Authority: 32 CFR 199.4(e)(3)

Revision: C-16, September 13, 2024

1.0 POLICY

The family planning procedures listed below may be cost-shared:

1.1 Surgical insertion, removal, and replacement of intrauterine devicesMedical contraceptives listed in Sections 2.1 and 2.2, as well as tubal ligation (see note below), are covered as the clinical preventive services benefit.

1.2 Measurement for, and purchase of, contraceptive diaphragms, including remeasurement and replacement.In addition to the medical contraceptives listed in Section 2.1 and 2.2, the family planning procedures listed below may also be cost-shared:

1.2.1 Prescription contraceptives, including diaphragms received in the pharmacy setting, and prescription contraceptives used as emergency contraceptives.

Note: Implantable prescription contraceptives are covered if the United States (US) Food and Drug Administration (FDA) approved and used for the labeled indication.

1.2.2 Surgical sterilization.

Note: Tubal ligation procedures are covered with no-cost sharing when performed by an in network provider for TRICARE Prime and TRICARE Select beneficiaries, effective January 1, 2023. However, cost-sharing may apply when performed by an out-of-network provider or when provided to non TRICARE Prime or TRICARE Select beneficiaries (i.e., TRICARE for Life (TFL) beneficiaries). See Section 2.2.

1.4 Male and female surgical sterilization.

2.0 EXCLUSIONS

2.1 Prophylactics (condoms).

2.2 Spermicidal foams, jellies, and sprays not requiring a prescription.

2.3 Services and supplies related to noncoital reproductive technologies, including but not limited to artificial insemination (including cost related to donors and semen banks), In Vitro Fertilization (IVF) and Gamete Intrafallopian Transfer (GIFT).

2.4 Male and female reversal of a surgical sterilization procedure, except medically necessary reversal of surgical sterilization for the treatment of a disease or injury (see Chapter 4, Sections 15.1 and 17.1).

2.5 For routine screening Papanicolaou (PAP) smear tests, routine gynelogic gynecologic examinations, and related laboratory testing, see the Preventive Services policy.

2.6 The family planning benefit does not include screening PAP smear tests, routine gynelogic gynecologic examinations, including related laboratory testing. However, family planning benefits may be allowed during an office visit for a screening PAP test.

- END -

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.